[1]常 旭,郭 志,于海鹏,等.氩氦刀冷冻消融挽救治疗胃癌肝转移患者[J].介入放射学杂志,2018,27(01):40-44.
　CHANG Xu,GUO Zhi,YU Haipeng,et al.Argon- helium knife cryoablation for the treatment of liver metastases from gastric cancer[J].journal interventional radiology,2018,27(01):40-44.
点击复制

氩氦刀冷冻消融挽救治疗胃癌肝转移患者()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
27
期数:
2018年01期
页码:
40-44
栏目:
非血管介入
出版日期:
2018-01-25

文章信息/Info

Title:
Argon- helium knife cryoablation for the treatment of liver metastases from gastric cancer
作者:
常 旭;  郭 志;  于海鹏;  司同国;  张炜浩;  杨雪玲
Author(s):
CHANG Xu;  GUO Zhi;  YU Haipeng;  SHI Tongguo;  ZHANG Weihao;  YANG Xueling
Department of Interventional Therapy， Cancer Hospital of Tianjin Medical University， National Clinical Research Center of Cancer， Key Laboratory of Cancer Prevention and Therapy of Tianjin， Tianjin 300060， China
关键词:
【关键词】 肝转移;  冷冻消融;  经皮穿刺消融;  安全性
文献标志码:
A
摘要:
【摘要】 目的 探讨氩氦刀冷冻消融挽救治疗胃癌肝转移患者的疗效及安全性。方法 回顾分析接受氩氦刀冷冻消融的24例胃癌肝转移患者的临床资料，其中33个可评价病灶。所有患者行CT引导下经皮穿刺肝转移瘤冷冻治疗，研究内容包括术后3个月、6个月及1年的肿瘤局部控制率，总生存率，疾病无进展生存时间，病灶的复发情况，术前术后患者生活质量变化情况及并发症。结果 患者中位随访时间为14（6～48）个月。冷冻消融术后患者生活质量明显提高，术后3个月、6个月及1年的病灶局部控制率分别为91.7%，73.9%，52.6%。经过冷冻消融治疗后，中位疾病无进展生存期为8（1～16）个月，患者中位生存时间为16个月，1年及2年生存率为75.0%及37.5%，未见严重并发症。结论 氩氦刀冷冻消融治疗胃癌肝转移，安全有效，近期疗效确切，可提高患者生活质量。

参考文献/References:

［1］ Sakamoto Y， Ohyama S， Yamamoto J， et al. Surgical resection of liver metastases of gastric cancer： an analysis of a 17- year experience with 22 patients［J］. Surgery， 2003， 133： 507- 511.
［2］ Yamamoto J， Shimada K， Kosuge T， et al. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases［J］. Br J Surg， 1999， 86： 332- 337.
［3］ Pawlik TM， Izzo F， Cohen DS， et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies： results in 172 patients［J］. Ann Surg Oncol， 2003， 10： 1059- 1069.
［4］ Ruers TJ， Joosten JJ， Wiering B， et al. Comparison between local ablative therapy and chemotherapy for non- resectable colorectal liver metastases： a prospective study［J］. Ann Surg Oncol， 2007， 14： 1161- 1169.
［5］ Bonomi AE， Cella DF， Hahn EA， et al. Multilingual translation of the Functional Assessment of Cancer Therapy （FACT） quality of life measurement system［J］. Qual Life Res， 1996， 5： 309- 320.
［6］ Watanabe H， Okada M， Kaji Y， et al. New response evaluation criteria in solid tumours- revised RECIST guideline（version 1.1） ［J］. Gan To Kagaku Ryoho， 2009， 36： 2495- 2501.
［7］ Moug SJ， Horgan PG. The role of synchronous procedures in the treatment of colorectal liver metastases［J］. Surg Oncol， 2007， 16： 53- 58.
［8］ Khatri VP， Chee KG， Petrelli NJ. Modern multimodality approach to hepatic colorectal metastases： solutions and controversies［J］. Surg Oncol， 2007， 16： 71- 83.
［9］ Page AJ， Weiss MJ， Pawlik TM. Surgical management of noncolorectal cancer liver metastases［J］. Cancer， 2014， 120： 3111- 3121.
［10］ Chen J， Tang Z， Dong X， et al. Radiofrequency ablation for liver metastasis from gastric cancer［J］. Eur J Surg Oncol， 2013， 39： 701- 706.
［11］ Lee CW， Kim JH， Won HJ， et al. Percutaneous radiofrequency ablation of hepatic metastases from gastric adenocarcinoma after gastrectomy［J］. J Vasc Interv Radiol， 2015， 26： 1172- 1179.
［12］ 黄 斌， 周 石． TACE联合氩氦刀冷冻术治疗巨块型肝细胞癌的临床研究［J］． 介入放射学杂志， 2011， 20： 28- 31．
［13］ 刘长富， 郭 志， 邢文阁， 等． 栓塞联合冷冻消融对比索拉菲尼治疗Ⅲ期肾癌疗效评价［J］． 介入放射学杂志， 2015， 24： 964- 968．
［14］ Cohen JK， Miller J， Ahmed SA， et al. Ten- year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy［J］. Urology， 2008， 71： 515- 518.
［15］ Cazzato RL， de Lara CT， Buy X， et al. Single- centre experience with percutaneous cryoablation of breast cancer in 23 consecutive non- surgical patients［J］. Cardiovasc Intervent Radiol， 2015， 38： 1237- 1243.
［16］ Kerkar S， Carlin AM， Sohn RL， et al. Long- term follow up and prognostic factors for cryotherapy of malignant liver tumors［J］. Surgery， 2004， 136： 770- 779.
［17］ Ng KM， Chua TC， Saxena A， et al. Two decades of experience with hepatic cryotherapy for advanced colorectal metastases［J］. Ann Surg Oncol， 2012， 19： 1276- 1283.
［18］ Li Z， Fu Y， Li Q， et al. Cryoablation plus chemotherapy in colorectal cancer patients with liver metastases［J］. Tumour Biol， 2014， 35： 10841- 10848.
［19］ Kim HR， Cheon SH， Lee KH， et al. Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma［J］. Int J Hyperthermia， 2010， 26： 305- 315.
［20］ Jahangeer S， Forde P， Soden D， et al. Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours［J］. Cancer Treat Rev， 2013， 39： 862- 871.
［21］ Yang Y， Wang C， Lu Y， et al. Outcomes of ultrasound- guided percutaneous argon- helium cryoablation of hepatocellular carcinoma［J］. J Hepatobiliary Pancreat Sci， 2012， 19： 674- 684.

相似文献/References:

[1]叶 萍,常兆华,韩宝三.乳腺肿瘤冷冻消融治疗的研究进展[J].介入放射学杂志,2011,(08):660.
　YE Ping,CHANG Zhao-hua,HAN bao-san.Research progress in cryoablation therapy for breast tumor[J].journal interventional radiology,2011,(01):660.
[2]刘长富,郭 志,司同国,等. 高迁移率族蛋白B1对激素难治性前列腺癌冷冻免疫反应的影响[J].介入放射学杂志,2013,(06):494.
　LIU Chang? fu,GUO Zhi,SI Tong? guo,et al. The effect of high mobility group protein B1 on cryoimmunologic reaction in hormone?蛳 refractory prostate cancer： an experimental study in rats[J].journal interventional radiology,2013,(01):494.
[3]韩宗宏,史东宏,许 健,等.氩氦刀联合动脉化疗栓塞治疗16例肾上腺恶性肿瘤[J].介入放射学杂志,2013,(07):553.
　HAN Zong? hong,SHI Dong? hong,XU Jian,et al.Argon?蛳 helium cryoablation combined with transcatheter arterial chemoembolization for the treatment of malignant adrenal neoplasms： initial experience in 16 cases[J].journal interventional radiology,2013,(01):553.
[4]叶伟东,纪建松,涂建飞,等.氩氦刀冷冻消融联合肝动脉栓塞化疗术治疗中晚期肝癌的疗效分析[J].介入放射学杂志,2015,(05):392.
　YE Wei dong,JI Jian song,TU Jian fei,et al.Argon helium cryoablation combined with transcatheter arterial chemoembolization for the treatment of advanced hepatocellular carcinoma： analysis of therapeutic effectiveness[J].journal interventional radiology,2015,(01):392.
[5]邵天朋,刘 丽,袁 磊,等.动脉栓塞联合氩氦刀序贯治疗小肾癌的临床疗效分析[J].介入放射学杂志,2015,(07):597.
　SHAO Tian- peng,LIU Li,YUAN Lei,et al.Sequential therapy of transcatheter arterial embolization combined with percutaneous argon- helium cryoablation for small renal cancers： analysis of clinical effect[J].journal interventional radiology,2015,(01):597.
[6]刘长富,郭 志,邢文阁,等.栓塞联合冷冻消融对比索拉菲尼治疗Ⅲ期肾癌疗效评价[J].介入放射学杂志,2015,(11):964.
　LIU Chang-fu,GUO Zhi,XING Wen-ge,et al.Efficacy comparison for the treatment of stage Ⅲ renal cell carcinoma： transcatheter renal arterial embolization combined with cryoablation vs. sorafenib[J].journal interventional radiology,2015,(01):964.
[7]武 清,顾小强,徐家华,等.冷冻消融治疗复发性盆腔和后腹肿瘤的应用 [J].介入放射学杂志,2017,(10):899.
　WU Qing,GU Xiaoqiang,XU Jiahua,et al.Application of cryoablation in treating recurrent pelvic and retroperitoneal tumors[J].journal interventional radiology,2017,(01):899.
[8]王莹娟,司同国,杨雪玲,等.冷冻消融联合内分泌治疗T3期转移性前列腺癌的临床疗效及预后分析 [J].介入放射学杂志,2018,27(04):327.
　WANG Yingjuan,SI Tongguo,YANG Xueling,et al.Cryoablation combined with endocrine therapy for T3 stage metastatic prostate cancer: clinical efficacy and prognostic analysis[J].journal interventional radiology,2018,27(01):327.
[9]张永远,王 猛,潘元威,等.CT引导氩氦刀冷冻消融治疗滑膜肉瘤的临床疗效初探[J].介入放射学杂志,2018,27(04):345.
　ZHANG Yongyuan,WANG Meng,PAN Yuanwei,et al.CT- guided argon- helium knife cryoablation for the treatment of synovial sarcomas： preliminary results of its clinical efficacy[J].journal interventional radiology,2018,27(01):345.
[10]王辅明,刘敬禹,杨朝爱,等.国产冷冻设备（靶向刀）治疗肝癌临床应用[J].介入放射学杂志,2018,27(06):530.
　WANG Fuming,LIU Jingyu,YANG Chaoai,et al.Clinical application of domestic cryoablation device in the treatment of liver carcinomas[J].journal interventional radiology,2018,27(01):530.

备注/Memo

备注/Memo:
（收稿日期：２０１7-０1-19）
（本文编辑：俞瑞纲）
更新日期/Last Update: 2018-01-26